Nuveen
GLSI icon

Nuveen’s Greenwich LifeSciences GLSI Stock Holding History

Nuveen’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-88,717
Closed -$2.13M – 3789
2026
Q1 		$2.13M Buy
+88,717
New +$2.31M ﹤0.01% 2254
2022
Q2 		– Sell
-9,575
Closed -$206K – 3342
2022
Q1 		$206K Hold
9,575
– – ﹤0.01% 3189
2021
Q4 		$264K Hold
9,575
– – ﹤0.01% 3196
2021
Q3 		$403K Buy
9,575
+3,183
+50% +$133K ﹤0.01% 3206
2021
Q2 		$287K Buy
+6,392
New +$242K ﹤0.01% 3223

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nuveen's GLSI Position: Q2 2026 in Review

Nuveen sold out of Greenwich LifeSciences (GLSI) in Q2 2026, closing a stake of 88,717 shares — an estimated $2.13M sold.

Nuveen first reported a position in GLSI in Q2 2021 and held it in 5 quarters. The position peaked at $2.13M in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Nuveen reported no remaining Greenwich LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 88,717 Greenwich LifeSciences shares in Q2 2026, an estimated $2.13M.
  • Nuveen first reported a position in Greenwich LifeSciences in Q2 2021 and held it in 5 quarters.
  • Nuveen's Greenwich LifeSciences position peaked at $2.13M in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.